{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T09:04:06Z","timestamp":1792919046894,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jtct.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T15:41:21Z","timestamp":1652542881000},"page":"349-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant"],"prefix":"10.1016","volume":"28","author":[{"given":"Dat","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6523-7621","authenticated-orcid":false,"given":"Jason","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8226-471X","authenticated-orcid":false,"given":"Monzr M.","family":"Al Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.05.012_bib0001","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0002","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood-2015-04-639831","article-title":"Haploidentical transplant with posttransplant cyclophosphamide versus matched unrelated donor transplant for acute myeloid leukemia","volume":"126","author":"Ciurea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.012_bib0003","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1182\/blood-2015-01-623991","article-title":"Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide","volume":"125","author":"McCurdy","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2022.05.012_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-018-0586-4","article-title":"Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT","volume":"11","author":"Ruggeri","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2022.05.012_bib0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/hematology.2019001323","article-title":"How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide","volume":"2019","author":"McCurdy","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2022.05.012_bib0006","unstructured":"Phelan R, Arora M, Chen M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2020. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/Documents\/US%202020%20Summary%20Slides%20-%20final%20-%20for%20web%20posting%20V2.pptx"},{"key":"10.1016\/j.jtct.2022.05.012_bib0007","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0008","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI128710","article-title":"Mechanism of action of posttransplantation cyclophosphamide: more than meets the eye","volume":"129","author":"Radojcic","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2022.05.012_bib0009","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2019.02668","article-title":"Mechanisms of graft-versus-host disease prevention by post-transplantation cyclophosphamide: an evolving understanding","volume":"10","author":"Nunes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00277-020-03930-w","article-title":"Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation","volume":"99","author":"Jaiswal","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0011","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.bbmt.2020.04.028","article-title":"Hemorrhagic cystitis after haploidentical transplantation with post-transplantation cyclophosphamide: protective effect of mesna continuous infusion","volume":"26","author":"Arango","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2022.05.012_bib0012","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/tid.13601","article-title":"Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation","volume":"23","author":"Kaphan","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2022.05.012_bib0013","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2022.05.012_bib0014","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/bmt.2017.111","article-title":"Single-agent GvHD prophylaxis with tacrolimus after post-transplant high-dose cyclophosphamide is a valid option for haploidentical transplantation in adults with hematological malignancies","volume":"52","author":"Esquirol","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41409-019-0726-7","article-title":"Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies","volume":"55","author":"Peric","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0016","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/s41409-021-01364-0","article-title":"Use of high-dose mesna and hyperhydration leads to lower incidence of hemorrhagic cystitis after posttransplant cyclophosphamide-based allogeneic transplantation","volume":"56","author":"Mac","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0017","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/bloodadvances.2020001648","article-title":"Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults","volume":"4","author":"Symons","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.012_bib0018","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","article-title":"High-dose cyclophophosphamide as single-agent short-course prophylaxis of graft-versus-host disease","volume":"115","author":"Luznik","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.012_bib0019","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbmt.2018.12.142","article-title":"Higher incidence of hemorrhagic cystitis following haploidentical related donor transplantation compared with matched related donor transplantation","volume":"25","author":"Copelan","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type","volume":"95","author":"Silva Lde","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2022.05.012_bib0021","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.jtct.2022.05.012_bib0022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.seminhematol.2019.03.005","article-title":"Immune reconstitution after T-cell replete HLA-haploidentical transplantataion","volume":"56","author":"McCurdy","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0023","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/17474086.2020.1796621","article-title":"Evolution of the role of haploidentical stem cell transplantation: past, present, and future","volume":"13","author":"Kwon","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0024","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejh.13321","article-title":"Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia","volume":"103","author":"Salas","year":"2019","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0025","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0026","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/bloodadvances.2020003779","article-title":"A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation","volume":"5","author":"Bejanyan","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.012_bib0027","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s15010-017-1016-1","article-title":"A review of infectious complications after haploidentical hematopoietic stem cell transplantation","volume":"45","author":"Atilla","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jtct.2022.05.012_bib0028","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12365","article-title":"Infection after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis","volume":"17","author":"Crocchiolo","year":"2015","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jtct.2022.05.012_bib0029","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.bbmt.2018.12.441","article-title":"Influence of the Intensity of the allogeneic conditioning regimen on the risk of hemorrhagic cystitis (HC) in patients receiving post-transplant cyclophosphamide (PT-Cy) as GVHD prophylaxis","volume":"25","author":"Mukherjee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0030","article-title":"Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis","author":"Guti\u00e9rrez-Aguirre","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.012_bib0031","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood.V128.22.3418.3418","article-title":"Hemorrhagic cystitis in haploidentical hematopoietic stem cell transplant: retrospective study and comparison with a NON-Haploidentical DONOR Transplant Group","volume":"128","author":"Arratibel","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.012_bib0032","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41409-020-0921-6","article-title":"Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors","volume":"55","author":"Montoro","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0033","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00277-018-3433-3","article-title":"Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients","volume":"97","author":"Brunello","year":"2018","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.jtct.2022.05.012_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2020.12.006","article-title":"Outpatient haploidentical stem cell transplantation using post-transplant cyclophosphamide is safe and feasible","volume":"27","author":"Colunga-Pedraza","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.05.012_bib0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41409-020-01092-x","article-title":"Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching","volume":"56","author":"Irene","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0036","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1038\/s41409-021-01328-4","article-title":"Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide","volume":"56","author":"Esquirol","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0037","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.micinf.2012.02.002","article-title":"BK polyomavirus emerging pathogen","volume":"14","author":"Bennett","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jtct.2022.05.012_bib0038","first-page":"12","article-title":"ECIL-6 Group et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jtct.2022.05.012_bib0039","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1182\/blood-2003-08-2815","article-title":"Hemorrhagic cystitis after allogenic hematopoietic stem cell transplantation: donor type matters","volume":"103","author":"El-Zimaity","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.012_bib0040","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1182\/bloodadvances.2021004192","article-title":"Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant","volume":"5","author":"Al Malki","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.05.012_bib0041","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00277-020-04317-7","article-title":"Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation","volume":"100","author":"Bailen","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0042","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41409-019-0771-2","article-title":"Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature","volume":"55","author":"Garcia-Cadenas","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0043","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1182\/blood-2019-127651","article-title":"Effect of cyclophosphamide on hemorrhagic cystitis following haploidentical related compared to matched related\/unrelated donor hematopoietic stem cell transplantation: a 7-year tertiary center analysis","volume":"134","author":"Seval","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.012_bib0044","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/106002809502900914","article-title":"Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy","volume":"29","author":"Haselberger","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jtct.2022.05.012_bib0046","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.1991.9.11.2016","article-title":"Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation","volume":"9","author":"Shepherd","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0047","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.bbmt.2017.08.021","article-title":"Impact of fluid overload as new toxicity category on hematopoietic stem-cell transplant outcomes","volume":"23","author":"Rond\u00f3n","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0048","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.bbmt.2018.07.031","article-title":"Early fluid overload is associated with an increased risk of nonrelapse mortality after ex vivo CD34-selected allogeneic hematopoietic cell transplantation","volume":"24","author":"Rondon-Clavo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0049","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/s41409-019-0634-x","article-title":"Early fluid overload predicts higher non-relapse and overall mortality in adults after single-unit cord blood transplantation","volume":"54","author":"Konuma","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0050","first-page":"22","article-title":"Impact of fluid overload (FO) in post-transplant cyclophosphamide-based GVHD prophylaxis after allogeneic hematopoietic cell transplantation for hematological diseases","volume":"55","author":"Tran","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0051","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dulery","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.jtct.2022.05.012_bib0052","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-5347(01)67670-5","article-title":"Prevention of hemorrhagic cystitis following allogenic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: role of continuous bladder irrigation","volume":"153","author":"Turkeri","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0053","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1200\/JCO.1993.11.7.1306","article-title":"Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial","volume":"11","author":"Vose","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.012_bib0054","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/427291","article-title":"Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Leung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2022.05.012_bib0055","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2010.12.700","article-title":"Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Miller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0056","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/bmt.2013.62","article-title":"BK-virus prophylaxis: still no answer","volume":"48","author":"Phipps","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0057","article-title":"Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients","volume":"8","author":"Jandial","year":"2021","journal-title":"Ther Adv Infect Dis"},{"issue":"6","key":"10.1016\/j.jtct.2022.05.012_bib0058","doi-asserted-by":"crossref","first-page":"e13433","DOI":"10.1111\/tid.13433","article-title":"Fluoroquinolones for BK viral complication after transplantation: Meta-analysis","volume":"22","author":"Ito","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2022.05.012_bib0059","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.bmt.1705886","article-title":"Polyomavirus BK infection in blood and marrow transplant recipients","volume":"41","author":"Dropulic","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.012_bib0060","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jtct.2022.05.012_bib0061","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/00029330-200710010-00004","article-title":"Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease","volume":"120","author":"Xu","year":"2007","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jtct.2022.05.012_bib0062","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722012787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722012787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:48:10Z","timestamp":1726444090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722012787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2666636722012787"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.012","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}